Search Results - "Ilonczai, P."

Founder effect is responsible for the p.Leu131Phe heparin‐binding‐site antithrombin mutation common in Hungary: phenotype analysis in a large cohort by Gindele, R., Oláh, Z., Ilonczai, P., Speker, M., Udvari, Á., Selmeczi, A., Pfliegler, G., Marján, E., Kovács, B., Boda, Z., Muszbek, L., Bereczky, Z.

“…Essentials Antithrombin Budapest3 (ATBp3; p.Leu131Phe) causing heparin‐binding‐site defect is common. We studied the clinical and laboratory phenotype of a…”
Get full text

EFFICACY AND SAFETY OF NEMTABRUTINIB VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WITHOUT TUMOR PROTEIN 53 ABERRATIONS: THE OPEN-LABEL, RANDOMIZED, PHASE 3 BELLWAVE-008 STUDY by G Perini, M Hus, S Wu, P Ilonczai, C Chen, J Yang, M Farooqui, A Mcdonald

“…Objectives: Standard of care for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) include fludarabine plus cyclophosphamide and…”
Get full text

C0290: Diagnostic Considerations Based on the Experience of Genetic Analysis in Protein S Deficiency in the Hungarian Population with High Frequency of FV Leiden Mutation by Miklós, T, Oláh, Z, Schlammadinger, Á, Ilonczai, P, Pfliegler, G, Boda, Z, Bernadett Kovács, K, Gindele, R, Szabó, Z, Kerényi, A, Muszbek, L, Bereczky, Z

Get full text

Treatment of mantle cell lymphoma with autologous stem-cell transplantation in a patient with severe congenital haemophilia-A and chronic (B and C virus) hepatitis by REJTO, L., SCHLAMMADINGER, A., ILONCZAI, P., TORNAI, I., BATAR, P., REMENYI, GY, KISS, A., UDVARDY, M.

Get full text

P050 Successful immune tolerance induction treatment of therapy-resistent acquired haemophilia with high inhibitor titer: a case report by Ilonczai, P, Schlammadinger, Á, Oláh, Zs, Rázsó, K, Bereczky, Zs, Boda, Z

Get full text

P052 Low dose factor concentrate prophylaxis in patients with severe haemorrhagic disorders by Schlammadinger, Á, Ilonczai, P, Oláh, Zs, Rázsó, K, Boda, Z

Get full text

P049 Could heparin-induced thrombocytopenia and thrombosis be a rare manifestation of antiphospholipid antibody syndrome? by Olah, Z, Schlammadinger, A, Mikita, J, Ilonczai, P, Razso, K, Bereczky, Z, Boda, Z

Get full text

P168 Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab) by Ujj, Zs, Rejtö, L, Tornai, I, Kiss, A, Telek, B, Reményi, Gy, Ilonczai, P, Udvardy, M

Get full text

O26 A pilot study with autologous bone marrow-derived stem cell transplantation (ABSCT) in patients with severe peripheral arterial disorder (SPAD) by Boda, Z, Farkas, K, Tóth, J, Jámbor, L, Soltész, P, Rázsó, K, Sipos, T, Szarvas, M, Oláh, Zs, Ilonczai, P, Litauszky, K, Veréb, Z, Rajnav¨olgyi, E

Get full text

P018 Autologous bone marrow-derived stem cell transplantation in severe peripheral arterial disorder: the first five patients in Hungary by Szarvas, M, Rázsó, K, Oláh, Zs, Ilonczai, P, Farkas, K, Tóth, J, Jámbor, L, Soltész, P, Litauszky, K, Hunyadi, J, Sipos, T, Kappelmayer, J, Veréb, Z, Rajnav¨olgyi, É, Boda, Z

Get full text

OC 17.3 Prothrombotic Polymorphisms FV Leiden and Prothrombin G20210A in 699 Unrelated Patients with Congenital Antithrombin Deficiency: More than a Prognostic Value by Bravo Perez, C., Orlando, C., Gindele, R., Cifuentes, R., Stouffs, K., Ilonczai, P., de la Morena-Barrio, M., Schlammadinger, Á., Pfliegler, G., Corral, J., Jochmans, K., Bereczky, Z.

Get full text

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy by Bödör, Csaba, Kotmayer, Lili, László, Tamás, Takács, Ferenc, Barna, Gábor, Kiss, Richárd, Sebestyén, Endre, Nagy, Tibor, Hegyi, Lajos László, Mikala, Gábor, Fekete, Sándor, Farkas, Péter, Balogh, Alexandra, Masszi, Tamás, Demeter, Judit, Weisinger, Júlia, Alizadeh, Hussain, Kajtár, Béla, Kohl, Zoltán, Szász, Róbert, Gergely, Lajos, Gurbity Pálfi, Timea, Sulák, Adrienn, Kollár, Balázs, Egyed, Miklós, Plander, Márk, Rejtő, László, Szerafin, László, Ilonczai, Péter, Tamáska, Péter, Pettendi, Piroska, Lévai, Dóra, Schneider, Tamás, Sebestyén, Anna, Csermely, Péter, Matolcsy, András, Mátrai, Zoltán, Alpár, Donát

“…Summary The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib has revolutionised the therapeutic landscape of chronic lymphocytic leukaemia (CLL). Acquired…”
Get full text

Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation by László, Tamás, Kotmayer, Lili, Fésüs, Viktória, Hegyi, Lajos, Gróf, Stefánia, Nagy, Ákos, Kajtár, Béla, Balogh, Alexandra, Weisinger, Júlia, Masszi, Tamás, Nagy, Zsolt, Farkas, Péter, Demeter, Judit, Istenes, Ildikó, Szász, Róbert, Gergely, Lajos, Sulák, Adrienn, Borbényi, Zita, Lévai, Dóra, Schneider, Tamás, Pettendi, Piroska, Bodai, Emese, Szerafin, László, Rejtő, László, Bátai, Árpád, Dömötör, Mária Á, Sánta, Hermina, Plander, Márk, Szendrei, Tamás, Hamed, Aryan, Lázár, Zsolt, Pauker, Zsolt, Radványi, Gáspár, Kiss, Adrienn, Körösmezey, Gábor, Jakucs, János, Dombi, Péter J, Simon, Zsófia, Klucsik, Zsolt, Gurzó, Mihály, Tiboly, Márta, Vidra, Tímea, Ilonczai, Péter, Bors, András, Andrikovics, Hajnalka, Egyed, Miklós, Székely, Tamás, Masszi, András, Alpár, Donát, Matolcsy, András, Bödör, Csaba

“…TP53 aberrations predict chemoresistance and represent a contraindication for the use of standard chemoimmunotherapy in chronic lymphocytic leukaemia (CLL)…”
Get full text

COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME? by Oláh, Z., Schlammadinger, A., Mikita, J., Ilonczai, P., Rázsó, K., Bereczky, Z., Boda, Z.

Get full text

Treatment of mantle cell lymphoma with autologous stem-cell transplantation in a patient with severe congenital haemophilia-A and chronic (B and C virus) hepatitis by Rejto, L, Schlammadinger, A, Ilonczai, P, Tornai, I, Batar, P, Remenyi, Gy, Kiss, A, Udvardy, M

Get full text